10302-79-1 Usage
Description
3',5'-di-o-toluoyl-2-deoxy-5-azacytosine, also known as 1-(2'-Deoxy-3',5'-di-O-toluoyl-β-D-ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,2,3,5-triazine, is a white crystalline solid compound with a unique chemical structure. It is primarily used in organic synthesis due to its distinctive properties and potential applications in various fields.
Uses
Used in Organic Synthesis:
3',5'-di-o-toluoyl-2-deoxy-5-azacytosine is used as a synthetic building block for the creation of complex organic molecules. Its unique structure allows it to be a valuable component in the synthesis of various compounds, contributing to the development of new materials and pharmaceuticals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3',5'-di-o-toluoyl-2-deoxy-5-azacytosine is used as an intermediate in the development of new drugs. Its specific chemical properties make it a promising candidate for the synthesis of novel therapeutic agents, potentially leading to the discovery of innovative treatments for various diseases.
Used in Chemical Research:
3',5'-di-o-toluoyl-2-deoxy-5-azacytosine is also utilized in chemical research as a model compound to study the properties and behavior of similar structures. This helps researchers gain a deeper understanding of the underlying chemistry, which can be applied to the design and synthesis of new molecules with specific functions and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 10302-79-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,3,0 and 2 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 10302-79:
(7*1)+(6*0)+(5*3)+(4*0)+(3*2)+(2*7)+(1*9)=51
51 % 10 = 1
So 10302-79-1 is a valid CAS Registry Number.
10302-79-1Relevant articles and documents
Method for synthesizing decitabine intermediate
-
Paragraph 0037, (2020/01/25)
The invention relates to a method for synthesizing a decitabine intermediate, in particular to a method for synthesizing the decitabine intermediate with a structure shown in a formula 2. According tothe method, the purity of the intermediate can be greatly improved, so that the purification operation of decitabine is reduced, a transition state intermediate compound is successfully separated forthe first time, and the total yield of decitabine is increased by three times.
